Introduction
Leishmaniasis is one of the most diverse and complex of all vector borne diseases. It is caused by an obligated intracellular protozoa parasite belonging to the genus Leishmania. The disease affects approximately 12 million people from 88 countries, with an increasing incidence of 1.5-2.0 million new cases diagnosed every year and 350 million people at risk. It is manifested mainly in three clinical forms: cutaneous, mucocutaneous and visceral leishmaniasis, from which the visceral disease constitutes the fatal form if untreated [1, 2] .
In the current scenario, the chemotherapy is one of the promising actions to control the disease. Conventional drugs have serious limitations such as high cost, toxicity, difficult route of administration and lack of efficacy in endemic areas. The development of safe, effective and affordable antileishmanial agents is a need [3] . In endemic areas, the population use plants to treat many infectious diseases, including leishmaniasis [4] . Cuba is well known for rich flora with a high percentage of endemic species. It is considered as an interesting source of plant species for searching bioactive metabolites. The genus Pluchea contains many species with important medicinal properties [5] . The genus includes 80 species from which [30] [31] [32] [33] [34] [35] [36] [37] [38] [39] [40] live in tropical regions (6) and only three of them are Cuban: Pluchea carolinensis (P. carolinensis)(Jacq.) G. Don., Pluchea odorata (P. odorata) (Sw.) DC. and Pluchea rosea (P. rosea) Godfrey. The Cuban species of Pluchea are well known for their ethnomedical use, including headaches, fever and slow digestions. Antimicrobial properties of different plant organs of some species of the genus Pluchea have been tested against bacterias, fungi and viruses [5, 7] . On the other hand, some chemical studies have been carried out in the genus Pluchea. The most widely distributed metabolites are terpenoids followed by flavonoids [5] and it's well known that these kinds of phytochemicals have antileishmanial activity [8, 9] . The present study is to evaluate Objective: To evaluate the antileishmanial activity of different extracts from three Cuban Pluchea species. Methods: In in vitro assays the IC 50 was calculated in the promastigotes and amastigotes forms as cytotoxicity in murine macrophages. In leishmaniasis cutanea experiment, mortality, weight loss, lesion size and burden parasite were measured. Results: Extracts evaluated showed inhibitive effect on growing of promastigote form; however, active extracts caused a high toxicity. Ethanol and n-hexane extracts demonstrated specific antileishmanial activity. Ethanol and n-hexane extracts from Pluchea carolinensis (P. carolinensis) caused similar inhibition against amastigote form. The intraperitoneal administration of the ethanol extract of P. carolinensis at 100 mg/kg prevented lesion development compared with control groups. Conclusions: The antileishmanial experiment suggests that ethanol extracts from P. carolinensis is the most promising. Further studies are still needed to evaluate the potential of this plant as a source of new antileishmanial agents. the antileishmanial activity of different extracts from three Cuban Pluchea species.
Materials and methods

Extracts from P. carolinensis
Samples of P. carolinensis (HAC 41725) were collected in "Sierra del Rosario" (Pinar del Río) in March 2006; while P. rosea (LS 16648) and P. odorata (LS 17198) were collected in "Ciénaga de Zapata" (Matanzas) in May 2006. The blooming specimens were deposited in the HAC herbarium of the "Instituto de Ecología y Sistemática" (Havana), Cuba. Leaves of plants were extracted at room temperature during 3 days. The hydroalcoholic solution (70% ethanol) was pooled, evaporated and subjected to liquid-liquid extractions with solvents of increasing polarity [10] . One liter of the solutions was extracted eight times in a separating funnel, firstly with 400 mL of n-hexane and the other times with 200 mL each one. The n-hexane solution was pooled, filtered and dried at low pressure until n-hexane crude extracts was obtained. The same methodology was followed up by chloroform, ethyl acetate and n-butyl alcohol. All extractions were performed in duplicates. After evaporation, dried samples were dissolved in dimethyl sulfoxide (DMSO) at 20 mg/mL.
Parasite culture
Leishmania amazonensis (L. amazonensis) (MHOM/77BR/ LTB0016) was kindly provided by the Department of Immunology, Oswaldo Cruz Foundation (FIOCRUZ), Brazil. Parasites were routinely isolated from mouse lesions and maintained as promastigotes at 26 ℃ in Schneider's medium (SIGMA, St. Louis, MO, USA) containing 10% heatinactivated fetal bovine serum (HFBS) (SIGMA, St. Louis, MO, USA), streptomycin 100 毺 g/mL, and penicillin 100 U/mL. All parasites were not used after the tenth passage.
Laboratory animals
Female BALB/c mice, with a body weight of approximately 20-22 g, were obtained from National Center of Laboratory Animals Production (CENPALAB). The maintenance and care of mice was followed according to guidelines from Ethics Committee for the Human Use of Laboratory Animals. The temperature and humidity were controlled, with 12 h light/ dark cycle and given water and food ad libitum for all animals.
Reference drug
As a drug reference amphotericin B (AmB, IMEFA, Cuba) was used at a concentration of 2 mg/mL. The drug was diluted in sterile distilled water.
In vitro evaluations
Antipromastigote assay
Promastigotes of L. amazonensis (10 5 promastigotes/mL) were distributed in 96-well plates, treated with 1 毺 L of extracts or DMSO, and then incubated at 26 ℃. After 72 h, the parasites were incubated for 3 h with P-nitrophenol phosphate (20 mg/mL) dissolved in 1 mol/L sodium acetate buffer (BDH, Poole, England), pH 5.5, with 1% Triton 伊 -100 (BDH, Poole, England) at 37 ℃. The absorbance was determined in an EMS Reader MF Version 2.4-0, at a wavelength of 405 nm [11] .
Cytotoxicity assay
Peritoneal macrophages were collected from normal BALB/c mice in RPMI 1640 medium (SIGMA, St. Louis, Mo, USA) supplemented with antibiotics, and seeded at 30 000 cell/well. The cells were incubated for 2 h at 37 ℃ in 5% CO 2 and non-adherent cells were removed. Dilutions of the extracts or DMSO were added and incubated in the same conditions during 72 h. The viability was determined adding 15 
Louis, MO, USA) at 5 mg/mL. After incubation for an additional 4 h the formazan crystals were dissolved by addition of 100 毺 L DMSO. The optical density was determined using an EMS Reader MF Version 2.4-0, at a test wavelength of 560 nm and a reference wavelength of 630 nm [12] .
Antiamastigote assay
The peritoneal macrophages monolayer was obtained and infected with stationary-phase L. amazonensis promastigotes at 4:1 parasite/macrophage ratio and incubated for further 4 h. The monolayer's cell was washed and treated with 1 毺 L of extracts or DMSO for further 48 h. Parasites were then fixed, stained with Giemsa, and examined under light microscopy [13] . The number of intracellular amastigotes and infected macrophage was determined by counting and the percent of inhibition were calculated in comparison to cultures treated with DMSO[14] .
The medium inhibitory concentration (IC 50 ) value and medium cytotoxicity concentration (IC 50 ) were determined from the lineal concentration-response curves. The selectivity index (SI) ratio was calculated trough division of IC 50 for macrophage by IC 50 for promastigotes [15] .
2.6. In vivo studies
Infection and treatment
On day 0, mice were infected with 10 7 logarithmic promastigotes by subcutaneous route in the right footpads. On day 15 post-infection (pi.), mice were randomly divided into four groups: two control groups (one group treated with vehicle and other one untreated), one group treated with extract 100 mg/kg, and the last group treated with amphotericin B 1 mg/kg. Treatment was administered daily by intraperitoneal route from day 15 pi. to the day 30 pi.
2.6.2.Biological evaluation
Animals were checked daily to record the death and the individual corporal weigh were determined each 7 days. Disease progression was monitored by measuring footpads swelling, using an automatic calliper. Average lesion size was calculated as the differences obtained between infected and uninfected footpads. On day 45 pi., six animals of each group were killed by cervical dislocation and the parasite burden was determined using the culture microtitration method described by Buffet and collaborators [16] . 
Statistical analyses
Results
The three extracts evaluated inhibited promastigotes form growing. P. carolinensis extracts showed the best activity, with IC 50 values below of 100 毺 g/mL from all extracts, except for n-butanol extract. The active extracts caused a high toxicity; although the ethanol and n-hexane extracts demonstrated the more specific antileishmanial activity ( Table 1 ). The ethanol and n-hexane extracts from P. carolinensis caused similar inhibition against amastigote form, which IC 50 values of 30.9 毺 g/mL and 29.6 毺 g/mL, respectively. Amphotericin B showed an IC 50 of 0.034 毺 g/mL.
The intraperitoneal administration of the ethanol extract of P. carolinensis at 100 mg/kg prevented lesion development compared with the animals treated with the vehicle, untreated mice, as well as mice treated with amphotericin B (P<0.05). However, the treatment with n-hexane extract did not decrease the lesion size (P>0.05) respecting untreated animals. These results were corroborated when the parasite burden was determined (Figure 1 
Discussion
Plant extracts or plants-derived compounds are likely to provide a valuable source of new medicinal agents [17, 18] and the urgent need for alternative treatments has led to a program to screen natural products for potential use in therapy of leishmaniasis. The leishmanicidal activity of several extracts has been evaluated on different plant family [19] . Approximately, 20 different species of Asteraceae family [4, 20, 21] have demonstrated to have antileishmanial potentialities. Among them, the genus Pluchea has been the less explored, but reports shows that some species of the genus have been identified as sources of antimicrobial crude extracts [5] . In addition, etnobotanical reports have described the use of P. carolinensis to treat migraine in Puerto Rico population [22] and P. odorata as anticancer in Guatemala [23] . Here, we report for the first time the antileishmanial evaluation of different extracts from three species of Pluchea.
Different in vitro activities against promastigote form were recorded of the extracts, which were prepared using different solvents, as well as cytotoxicity effect on macrophage from BALB/c mice. The best selectivity was demonstrated by ethanol and n-hexane extracts from P. carolinensis, which inhibited the growth of intracellular amastigote with an IC 50 value of 30 毺 g/mL, approximately. These results led us to evaluate both extracts in vivo with the aim to validate the antileishmanial potentialities of these plants.
The leaf ethanol extract from P. carolinensis showed the greatest activity in BALB/c mice experimentally infected. In addition, no death or weight losses higher than 10% were observed in the treated animals with the extract. Toxicity of natural products is important because of the interest in alternative therapies and the therapeutic use of medicinal plants in endemic populations, which should be safe to use. One limitation of conventional antileishmanial treatments result their side effects. Many people worldwide have no access to conventional pharmacological treatments but depend on folk remedies. The widespread use of traditional medicine suggests that natural products are harmless, but their safety require scientific demonstrations [24] .
The amphotericin B showed better activity in vitro compared with the extracts evaluated, which are complex mixture of substances. The purification of active compounds might result in a considerable increase of their antileishmanial activity. In addition, amphotericin B is a pure compound and constitutes the most active antileishmanial drug. Nevertheless, due to their toxicity the amphotericin B is considered as a second option in areas refractory to antimony [25, 26] . In contrast, experiment the ethanol extract from P. carolinensis cause higher efficacy against cutaneous leishmaniasis in vivo. Previous studies have suggested the low effect of amphotericin B against leishmaniasis caused by L. amazonensis in BALB/c mice [27, 28] .
Previously has been demonstrated that among the phenolic compounds, flavonoids are constituents from P. carolinensis extracts. In deep, aglycone flavonols with kaempferol, myricetin and quercetin skeletons were detected from crude ethylacetate extract, in (374 依 1), (62 依 3) and (2 622 依 2) 毺 g per gram of leaf dry weight/g, respectively [29] . These flavonols have hydroxyl group in the positions 3′ and 4′ of the flavan skeleton. In this sense, the 3′,4′,5,6,7-pentahydroxy-3-methoxyflavone was also identified from leaves of P. carolinensis [30] . So, it is possible that these flavonols would be responsible in part for the antileishmanial activity found for this extract. In addition, some terpenoids with skeleton type cuauthemone and eudesmane [31] have been isolated from crude leaf extract from the species Pluchea carolinensis. This kind of phytochemicals could be also the responsible of the antileishmanial activity found in the nonpolar extract.
The mechanism of action related with antileishmanial activity of P. carolinensis has not been studied, although in this study we demonstrated their direct effect on Leishmania parasites growing. In addition, Rosales et al reported the anti-inflamatory effect of P. carolinensis extracts [32] , which could influence the decreased of lesion growing. During the infection by Leishmania parasite occurs an inflammatory process in the site of infection due to the influx of cytokines and others effectors cells of the immune system, which have direct relation with lesion size [11] .
The assessment of different extracts from three Cuban species of the genus Pluchea could suggest that P. carolinensis is the most promising species among the studied and further studies can be performe to evaluate the flavonols compounds isolated from this plant as a source of new antileishmanial agent.
